The use of a synthetic prostaglandin E1 analog as a gastric protectant against aspirin-induced hemorrhage in the dog

Journal of the American Animal Hospital Association

Volumn 32, Issue 5, 1996, Pages 401-407

  Bowersox, Thomas S ^a   Lipowitz, Alan J ^a   Hardy, Robert M ^a   Johnston, Gary R ^a   Hayden, David W ^a   Schwartz, Samuel ^a   King, Vickie L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ACETYLSALICYLIC ACID; MISOPROSTOL; DRUG DERIVATIVE; HEMOGLOBIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOG; DRUG EFFICACY; ENDOSCOPY; FEMALE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; STOMACH HEMORRHAGE; STOMACH INJURY; ANIMAL; ANIMAL DISEASE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOG DISEASE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; FECES; GASTROINTESTINAL HEMORRHAGE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STOMACH; STOMACH DISEASE;

ALPROSTADIL; ANIMALS; ASPIRIN; BODY WEIGHT; DIARRHEA; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FECES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; MALE; MISOPROSTOL; PROSTAGLANDINS, SYNTHETIC; STOMACH; STOMACH DISEASES;

EID: 0029662343     PISSN: 05872871     EISSN: None     Source Type: Journal    
DOI: 10.5326/15473317-32-5-401     Document Type: Article

References (30)

1. Kuo YJ, Shambour LL. Mechanism of aspirin on canine gastric mucosa. Am J Physiol 1976;230:762-7.
2. Rainsford KD. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1989,24(Suppl 163):9-16.
3. Twedt DC, Magne ML. Diseases of the stomach. In: Ettinger SJ, ed. Textbook of veterinary internal medicine: diseases of the dog and cat. 3rd ed. Philadelphia: WB Saunders, 1989:1300.
4. Robert A, Nezamis JE, Phillips JP. Inhibition of gastric secretion by prostaglandins. Am J Dig Dis 1967;12:1073-6.
5. Bauer RF. Misoprostol preclinical pharmacology Dig Dis Sci 1985;30:118s-25s.
6. Collins PW. Misoprostol: discovery, development, and clinical applications. Med Res Rev 1990;10:149-72.
7. Dajani EZ, Nissen BA. Gastrointestinal cytoprotective effects of misoprostol - clinical efficacy overview. Dig Dis Sci 1985;30:194s-200s.
8. Brand DL, Roufail WM, Thomson ABR, Tapper EJ. Misoprostol, a synthetic PGE analog, in the treatment of duodenal ulcers: a multicenter double-blind study. Dig Dis Sci 1985;30:147s-58s.
9. Sontag SJ, Mazure PA, Pontes JF, et al. Misoprostol in the treatment of duodenal ulcer: a multicenter double-blind placebo-controlled study. Dig Dis Sci 1985;30:159s-63s.
10. Agrawal NM, Saffouri B, Kruss DM, et al. Healing of benign gastric ulcer: a placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E. Dig Dis Sci 1985;30:164s-70s.
11. Silverstein FE, Kimmey MB, Saunders DR, Levine DS. Gastric protection by misoprostol against 1300 mg of aspirin: an endoscopic study. Dig Dis Sci 1986;31:137s-41s.
12. Ryan JR, Vargas R, Clay GA, McMahon GF. Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients. Am J Med 1987;83(Suppl 1A).41-4.
13. Roth S, Agrawal N, Mahowald M, et al Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Int Med 1989;149:775-9.
14. Cohen MM, Clark L, Armstrong L, D'Souza J. Reduction in aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. Dig Dis Sci 1985;30.605-11.
15. I (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs. J Am Vet Med Assoc 1993;202:251-6.
16. Johnston SA, Leib MS, Forrester SD, Marini M. The effect of misoprostol on aspirin-induced gastroduodenal lesions in dogs. J Vet Int Med 1995;9:32-8.
17. Boulay JP, Lipowitz AJ, Klausner JS. Effects of cimetidine on aspirin-induced gastric hemorrhage in dogs Am J Vet Res 1986,47:1744-6.
18. Yeary RA. Aspirin dosages for the dog. J Am Vet Med Assoc 1975:167:63-4.
19. Lipowitz AJ, Boulay JP, Klausner JS. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products. Am J Vet Res 1986;47:1586-9.
20. Schoenhard G, Opperman J, Kohn FE. Metabolism and pharmacokinetic studies of misoprostol. Dig Dis Sci 1985;30:126s-8s.
21. Schwartz S, Dahl J, Ellefson MS, Ahlquist D. The "HemoQuant" test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials. Clin Chem 1983;29:2061-7.
22. Ahlquist DA, McGill DB, Schwartz S, et al. HemoQuant, a new quantitative assay for fecal hemoglobin comparison with hemoccult. Ann Int Med 1984; 101:297-302.
23. Boulay JP, Lipowitz AJ, Klausner JS, et al. Evaluation of a fluorometric method for the quantitative assay for fecal hemoglobin in the dog. Am J Vet Res 1986;47:1293-5.
24. 99mTC-labeled red blood cells: clinical application in nine dogs. Vet Radiol 1987;28:96-100.
25. 99m-labeled red blood cells in an experimental model. J Nucl Med 1987;28:514-20.
26. Milliken GA, Johnson DE. Analyzing a two-way treatment structure in a split-plot design with no replications. In: Milliken GA, Johnson DE, eds. Analysis of messy data. II. Nonreplicated experiments New York: Van Nostrand Reinhold, 1989:71-8.
27. Agresti A. Estimation theory for parametric models. In: Agresti A, ed. Categorical data analysis. New York: John Wiley & Sons, 1990:458-62.
28. Lockard VG, Boler R. Ultrastructure of a spiraled microorganism in the gastric mucosa of dogs. Am J Vet Res 1970;31:1453-62.
29. Paster BJ, Lee A, Fox JG, et al. Phylogeny of Helicobacter felis sp. nov.; Helicobacter mustelae, and related bacteria. Int J Syst Bacteriol 1991;41:31-8.
30. Bright-Asare P, Giannikopoulos MD, Whiten JT. Prostaglandins and chemotherapy-induced ulcers in dogs. Dig Dis Sci 1985;30 201s-3s.